INIFY LABORATORIES AB Market Cap ($30.74 Million)
Market Cap & Net Worth: INIFY LABORATORIES AB (WY60)
INIFY LABORATORIES AB market cap. INIFY LABORATORIES AB (F:WY60) has a market capitalization of $30.74 Million (€26.29 Million) as of November 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #23496 globally and #2053 in its home market, demonstrating a 3.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying INIFY LABORATORIES AB's stock price €0.40 by its total outstanding shares 107474845 (107.47 Million). Also see WY60 cash generation efficiency for how efficiently the company converts equity into cash flow.
INIFY LABORATORIES AB Market Cap History (2022–2026)
INIFY LABORATORIES AB market cap history from 2022 to 2026. Data shows change from $96.25 Million to $50.01 Million (-11.57% CAGR). Check WY60 share price today for real-time trading data and today's change.
INIFY LABORATORIES AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how INIFY LABORATORIES AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of INIFY LABORATORIES AB to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.29x
INIFY LABORATORIES AB's market cap is 1.29 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $122.38 Million | $1.19 Million | -$53.33 Million | 102.58x | N/A |
| 2024 | $43.22 Million | $13.13 Million | -$51.64 Million | 3.29x | N/A |
| 2025 | $28.40 Million | $22.01 Million | -$67.89 Million | 1.29x | N/A |
Competitor Companies of WY60 by Market Capitalization
Companies near INIFY LABORATORIES AB in the global market cap rankings as of November 1, 2026. Also see WY60 total asset value for a full breakdown of the balance sheet.
Key companies related to INIFY LABORATORIES AB by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $164.04 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #530 globally with a market cap of $51.40 Billion USD ( CN¥351.23 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $697.00 |
| #143 | Danaher Corporation | NYSE:DHR | $164.04 Billion | $232.23 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $414.30 |
| #530 | WuXi AppTec Co Ltd | SHG:603259 | $51.40 Billion | CN¥142.01 |
Market Capitalization of INIFY LABORATORIES AB (2022–2026)
Market capitalization of INIFY LABORATORIES AB from 2022 to today. Between 2022 and today, INIFY LABORATORIES AB's market cap moved from $96.25 Million to $ 50.01 Million, with a yearly change of -11.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €50.01 Million | +76.11% |
| 2025 | €28.40 Million | -34.30% |
| 2024 | €43.22 Million | -64.68% |
| 2023 | €122.38 Million | +27.15% |
| 2022 | €96.25 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of INIFY LABORATORIES AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $30.74 Million USD |
| MoneyControl | $30.74 Million USD |
| MarketWatch | $30.74 Million USD |
| marketcap.company | $30.74 Million USD |
| Reuters | $30.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About INIFY LABORATORIES AB
INIFY Laboratories AB provides cancer diagnostics services in Sweden. It offers prostate cancer diagnostics services. The company was incorporated in 2021 and is based in Stockholm, Sweden.